H Lim Selected Research

H Lim Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 09/2009
3	Ischemia 03/2001 - 10/2000
3	Reperfusion Injury 03/2001 - 10/2000
2	Hypertension (High Blood Pressure) 10/2018 - 11/2006
2	Heart Failure 11/2006 - 02/2001
2	Asthma (Bronchial Asthma) 04/2002 - 06/2001
2	Respiratory Hypersensitivity 04/2002 - 06/2001
1	Pityriasis Rubra Pilaris 12/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Osteoarthritis 01/2019
1	Obesity 10/2018
1	Disease Progression 12/2017
1	Esophageal Squamous Cell Carcinoma 10/2017
1	Weight Gain 01/2017
1	Prognathism 09/2016
1	T-Lymphocytopenia 08/2012
1	HIV Infections (HIV Infection) 08/2012
1	Atrophy 09/2009
1	Carcinogenesis 09/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2009
1	Prostatic Neoplasms (Prostate Cancer) 09/2009
1	Hearing Loss (Hearing Impairment) 06/2009
1	Poisoning 04/2009
1	Vomiting 04/2009
1	Nausea 04/2009
1	Hemorrhage 12/2008
1	Fibrosis (Cirrhosis) 11/2006
1	Arthritis (Polyarthritis) 12/2001
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2001
1	Hypertrophy 02/2001
1	Cardiomyopathies (Cardiomyopathy) 02/2001
1	Hepatocellular Carcinoma (Hepatoma) 02/2001
1	Gastric Fistula 01/2001
1	Peptic Ulcer (Peptic Ulcers) 01/2001
1	Duodenal Ulcer (Curling's Ulcer) 01/2001
1	Ulcer 01/2001
1	Stomach Neoplasms (Stomach Cancer) 01/2001
1	Hypersensitivity (Allergy) 01/2001
1	Infertility (Sterility) 11/2000
1	Gallstones (Gallstone) 01/2000

Drug/Important Bio-Agent (IBA)

3	Neuroprotective AgentsIBA 03/2001 - 10/2000
3	N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidineIBA 03/2001 - 10/2000
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2019 - 11/2006
2	Methacholine Chloride (Methacholine)FDA Link 04/2002 - 06/2001
1	RNA (Ribonucleic Acid)IBA 01/2022
1	secukinumabIBA 12/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	CarbohydratesIBA 10/2018
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 10/2018
1	AfatinibIBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Opioid Analgesics (Opioids)IBA 10/2017
1	IronIBA 01/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2017
1	CopperIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	CholesterolIBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 08/2012
1	Interleukin-2 (IL2)IBA 08/2012
1	ClusterinIBA 09/2009
1	RicinIBA 04/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2006
1	CytokinesIBA 12/2001
1	ParaquatIBA 09/2001
1	Chaperonin 60IBA 09/2001
1	Mitogen-Activated Protein KinasesIBA 02/2001
1	Glycogen Synthase (Synthase I)IBA 02/2001
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 02/2001
1	Protein Kinases (Protein Kinase)IBA 02/2001
1	CalcineurinIBA 02/2001
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2001
1	ferumoxides (Feridex)FDA Link 02/2001
1	DBM-819IBA 01/2001
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2001
1	Ethanol (Ethyl Alcohol)IBA 01/2001
1	Cysteamine (Mercaptamine)FDA Link 01/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2001
1	Fluorouracil (Carac)FDA LinkGeneric 01/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2001
1	Monoclonal AntibodiesIBA 01/2001
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2001
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2001
1	Histamine Antagonists (Antihistamines)IBA 01/2001
1	Thymidylate SynthaseIBA 01/2001
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2000

Therapy/Procedure

3	Therapeutics 12/2017 - 02/2001
2	Oral Administration 01/2001 - 10/2000
1	Genomic Medicine 01/2022
1	Osteotomy 09/2016
1	Therapeutic Embolization 01/2013
1	Skin Care 01/2013
1	Lasers (Laser) 09/2009
1	Cochlear Implants (Cochlear Implant) 06/2009
1	Lipectomy (Liposuction) 12/2008
1	Adjuvant Chemotherapy 01/2001
1	Gastrectomy 01/2000